CONDUIT PHARMACEUTICALS INC. Annual Operating Income (Loss) in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Conduit Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2022 to 2023.
  • Conduit Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$5.81M, a 1251% decline year-over-year.
  • Conduit Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$14.3M, a 217% decline year-over-year.
  • Conduit Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$5.26M, a 66.5% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$5.26M -$2.1M -66.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 -$3.16M Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.